There’s information. And then there’s PharmSource intelligence.

Our trend reports provide expert guidance you won’t find elsewhere.


Dose CMOs by the Numbers: Composition, Size, Market Share, Profitability and Outlook—2015 Edition

Learn why CMO industry growth is not sustainable, despite outpacing the overall bio/pharmaceutical industry during 2012-2014. CMOs, CDMOs and their investors must be alerted to this forecast and its implications. List price $3,275 / Client price $2,750.

CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance

A rising tide lifts all boats, yet this report shows that while the CMO industry has been able to ride along on the bio/pharma industry upswing, it remains unable to break out on a new trajectory. See how operating performance and innovation continue to be the big challenges. List price $1,975 / Client price $1,500.

The Demand and Supply for Contract Manufacturing of Cytotoxic Injectable Drugs Through 2019

CMOs making investment and strategic decisions regarding new cytotoxic injectable capacity and capabilities will find this report indispensable. Get critical insight into the dilemma faced by buyers and sellers by the projected supply/demand balance. List price $2,500 / Client price $2,000.


Order all 3 trend reports and receive a 10% discount.

Yes! Please process my order for the PDF report(s) selected below without delay!
I understand advance payment/PO is required.